NASDAQ:SINT • US8293927039
The current stock price of SINT is 2.87 USD. Today SINT is up by 4.36%. In the past month the price decreased by -2.38%. In the past year, price decreased by -16.08%.
ChartMill assigns a technical rating of 0 / 10 to SINT. When comparing the yearly performance of all stocks, SINT is a bad performer in the overall market: 83.92% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to SINT. SINT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
On November 12, 2025 SINT reported an EPS of -3.46 and a revenue of 208.00K. The company missed EPS expectations (-516.76% surprise) and beat revenue expectations (1.96% surprise).
7 analysts have analysed SINT and the average price target is 16.32 USD. This implies a price increase of 468.64% is expected in the next year compared to the current price of 2.87.
For the next year, analysts expect an EPS growth of 62.03% and a revenue growth -67.16% for SINT
Over the last trailing twelve months SINT reported a non-GAAP Earnings per Share(EPS) of -6.8. The EPS increased by 92.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -145.75% | ||
| ROE | -407.15% | ||
| Debt/Equity | 0 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.25 | 195.75B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.54 | 175.278B | ||
| SYK | STRYKER CORP | 23.71 | 140.034B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.01 | 106.692B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.85 | 48.896B | ||
| IDXX | IDEXX LABORATORIES INC | 40.4 | 48.604B | ||
| BDX | BECTON DICKINSON AND CO | 12.02 | 47.113B | ||
| RMD | RESMED INC | 20.12 | 36.847B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.07 | 34.468B | ||
| DXCM | DEXCOM INC | 26.66 | 26.455B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.82 | 18.25B | ||
| PODD | INSULET CORP | 36.85 | 16.923B | ||
| HOLX | HOLOGIC INC | 15.39 | 16.875B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 20 full-time employees. The company went IPO on 2014-02-11. The company is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. The company has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. The company manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
IPO: 2014-02-11
SINTX TECHNOLOGIES INC
1885 West 2100 Street
Salt Lake City UTAH 84119 US
CEO: B. Sonny Bal
Employees: 20
Phone: 18018393516
SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 20 full-time employees. The company went IPO on 2014-02-11. The company is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. The company has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. The company manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
The current stock price of SINT is 2.87 USD. The price increased by 4.36% in the last trading session.
SINT does not pay a dividend.
SINT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
SINTX TECHNOLOGIES INC (SINT) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
SINTX TECHNOLOGIES INC (SINT) has a market capitalization of 11.05M USD. This makes SINT a Nano Cap stock.